HiberGene Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Out of Business

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Liquidation

HiberGene General Information

Description

Developer of real-time molecular diagnostic tests designed to test for the direct detection of human infectious diseases. The company's tests utilize loop-mediated isothermal amplification, performed on a small, portable, and low-cost platform, enabling clinicians to diagnose their disease in near-patient settings such as clinical laboratories, emergency rooms, and delivery wards producing.

Contact Information

Website
www.hibergene.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Block 2, Bracken Business Park
  • Sandyford
  • Dublin D18 RR24
  • Ireland
Primary Industry
Diagnostic Equipment
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • Block 2, Bracken Business Park
  • Sandyford
  • Dublin D18 RR24
  • Ireland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HiberGene Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Bankruptcy: Liquidation 12-Sep-2022 Completed Bankruptcy: Liquidation
9. Accelerator/Incubator 18-Feb-2021 Completed Generating Revenue
8. Later Stage VC 21-Dec-2020 Completed Generating Revenue
7. Grant Cancelled Generating Revenue
6. Grant 20-May-2020 Completed Generating Revenue
5. Later Stage VC 21-Dec-2018 Completed Generating Revenue
4. Later Stage VC (Series B) 12-Apr-2017 Completed Generating Revenue
3. Grant 10-Feb-2016 Completed Generating Revenue
2. Later Stage VC (Series A) 01-Dec-2014 $2.64M $2.64M Completed Generating Revenue
1. Spin-Off 01-Jan-2009 Completed Startup
To view HiberGene’s complete valuation and funding history, request access »

HiberGene Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary 1,151 $0.012069 $1486.28 $1486.28 1x $1486.28 8.74%
Ordinary 20 $0.012069 $1474.45 $1474.45 1x $1474.45 0.15%
To view HiberGene’s complete cap table history, request access »

HiberGene Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of real-time molecular diagnostic tests designed to test for the direct detection of human infectious diseases
Diagnostic Equipment
Dublin, Ireland
12 As of 2022

Mechelen, Belgium
 

Nehren, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

HiberGene Competitors (31)

One of HiberGene’s 31 competitors is Biocartis, a Venture Capital-Backed company based in Mechelen, Belgium.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Biocartis Venture Capital-Backed Mechelen, Belgium
Hain Lifescience Corporate Backed or Acquired Nehren, Germany
T2 Biosystems Formerly VC-backed Lexington, MA
LEX Diagnostics Corporate Backed or Acquired Melbourn, United Kingdom
Nanomix Formerly VC-backed San Leandro, CA
You’re viewing 5 of 31 competitors. Get the full list »

HiberGene Patents

  • 3

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

HiberGene Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201919067-D0 Biological sample testing device Inactive 20-Dec-2019
GB-201820681-D0 Biological sample testing device Inactive 19-Dec-2018
GB-201721219-D0 Biological sample testing device Inactive 18-Dec-2017

HiberGene Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

HiberGene FAQs

  • When was HiberGene founded?

    HiberGene was founded in 2009.

  • Where is HiberGene headquartered?

    HiberGene is headquartered in Dublin, Ireland.

  • What is the size of HiberGene?

    HiberGene has 12 total employees.

  • What industry is HiberGene in?

    HiberGene’s primary industry is Diagnostic Equipment.

  • Is HiberGene a private or public company?

    HiberGene is a Private company.

  • What is HiberGene’s current revenue?

    The current revenue for HiberGene is .

  • How much funding has HiberGene raised over time?

    HiberGene has raised $16.9M.

  • Who are HiberGene’s competitors?

    Biocartis, Hain Lifescience, T2 Biosystems, LEX Diagnostics, and Nanomix are some of the 31 competitors of HiberGene.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process